United States · Platforms & data · Morningstar

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Published by Morningstar · United States 18 h ago

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Read the full article on Morningstar Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

MarketWatch

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Seeking Alpha

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Benzinga

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Share

Also worth reading

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Best Tech Stocks Right Now

Lear stock tumbles 15% on weak revenue outlook

Smarter Braking for Electric Travel Trailers

Amazon shares are tumbling after third-quarter earnings miss. Analysts say buy the dip